Migoprotafib (GDC-1971) (compound 199) is a SHP2 inhibitor. Migoprotafib inhibits the MAPK/ERK signaling pathway, and exhibits antitumor activity[1][2].
Molecular Weight:
454.53
Purity:
98.81
CAS Number:
[2377352-49-1]
Formula:
C25H26N8O
Target:
ERK,p38 MAPK,Phosphatase,SHP2
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted